Milestone Pharmaceuticals Beats Loss Expectations
Update: 2025-11-12
Description
Milestone Pharmaceuticals reports Q3 loss of $11.9M, beating analysts expectations; company loses $0.12 per share, surpassing predicted $0.17 loss.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
